Mount Yale Investment Advisors LLC Lowers Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Mount Yale Investment Advisors LLC reduced its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 14.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,457 shares of the company’s stock after selling 570 shares during the quarter. Mount Yale Investment Advisors LLC’s holdings in HealthEquity were worth $332,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of HQY. Wasatch Advisors LP increased its stake in shares of HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after buying an additional 483,269 shares during the period. Vaughan Nelson Investment Management L.P. grew its holdings in HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after acquiring an additional 226,563 shares in the last quarter. Barclays PLC increased its position in HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company’s stock valued at $13,628,000 after purchasing an additional 112,667 shares during the period. Thrivent Financial for Lutherans raised its holdings in shares of HealthEquity by 33.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock valued at $24,033,000 after purchasing an additional 73,404 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of HealthEquity in the 3rd quarter worth approximately $5,675,000. 99.55% of the stock is owned by institutional investors.

HealthEquity Trading Up 1.0 %

NASDAQ:HQY opened at $108.80 on Thursday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a fifty day simple moving average of $99.85 and a 200-day simple moving average of $88.02. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $111.36. The company has a market capitalization of $9.43 billion, a P/E ratio of 99.82, a PEG ratio of 1.86 and a beta of 0.54.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the company posted $0.40 EPS. On average, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages recently commented on HQY. BTIG Research boosted their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Royal Bank of Canada boosted their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. Mizuho assumed coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective on the stock. The Goldman Sachs Group began coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Finally, Barrington Research increased their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus target price of $110.71.

Insider Buying and Selling

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now directly owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. This trade represents a 21.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 34,289 shares of company stock worth $3,355,718. 2.20% of the stock is owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.